Peptide ARHGEF9 Inhibits Glioma Progression via PI3K/AKT/mTOR Pathway.

Huang J, Fu X, Xue Q, Ma P, Yin Y, Jiang M, Lu Y, Ying Q, Jiang J, He H, Wu D.

Open source

DOI
10.1155/2023/7146589
Published
2023-02-18
Container
Dis Markers
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2023/7146589,
  title = {Peptide ARHGEF9 Inhibits Glioma Progression via PI3K/AKT/mTOR Pathway.},
  author = {Huang J and  Fu X and  Xue Q and  Ma P and  Yin Y and  Jiang M and  Lu Y and  Ying Q and  Jiang J and  He H and  Wu D.},
  year = {2023},
  journal = {Dis Markers},
  doi = {10.1155/2023/7146589},
  url = {https://doi.org/10.1155/2023/7146589}
}

RIS

TY  - JOUR
TI  - Peptide ARHGEF9 Inhibits Glioma Progression via PI3K/AKT/mTOR Pathway.
AU  - Huang J
AU  -  Fu X
AU  -  Xue Q
AU  -  Ma P
AU  -  Yin Y
AU  -  Jiang M
AU  -  Lu Y
AU  -  Ying Q
AU  -  Jiang J
AU  -  He H
AU  -  Wu D.
PY  - 2023
JO  - Dis Markers
DO  - 10.1155/2023/7146589
UR  - https://doi.org/10.1155/2023/7146589
ER  - 

APA

J, H., X, F., Q, X., P, M., Y, Y., M, J., Y, L., Q, Y., J, J., H, H., & D., W. (2023). Peptide ARHGEF9 Inhibits Glioma Progression via PI3K/AKT/mTOR Pathway.. Dis Markers. https://doi.org/10.1155/2023/7146589

Source records